Journal article 458 views
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
Beth S. Woods,
Eleftherios Sideris,
Matthew R. Sydes,
Melissa R. Gannon,
Mahesh K.B. Parmar,
Mymoona Alzouebi,
Gerhardt Attard,
Alison J. Birtle,
Susannah Brock,
Richard Cathomas,
Prabir R. Chakraborti,
Audrey Cook,
William R. Cross,
David P. Dearnaley,
Joanna Gale,
Stephanie Gibbs,
John D. Graham,
Robert Hughes,
Rob J. Jones,
Robert Laing,
Malcolm D. Mason,
David Matheson,
Duncan B. McLaren,
Robin Millman,
Joe M. O'Sullivan,
Omi Parikh,
Christopher C. Parker,
Clive Peedell,
Andrew Protheroe,
Alastair W.S. Ritchie,
Angus Robinson,
J. Martin Russell,
Matthew S. Simms,
Narayanan N. Srihari,
Rajaguru Srinivasan,
John N. Staffurth,
Santhanam Sundar,
George N. Thalmann,
Shaun Tolan,
Anna T.H. Tran,
David Tsang,
John Wagstaff,
Nicholas D. James,
Mark J. Sculpher
European Urology Oncology, Volume: 1, Issue: 6, Pages: 449 - 458
Swansea University Author: John Wagstaff
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1016/j.euo.2018.06.004
Abstract
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
Published in: | European Urology Oncology |
---|---|
ISSN: | 25889311 |
Published: |
2018
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa47923 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2018-12-10T20:29:25Z |
---|---|
last_indexed |
2018-12-27T20:03:22Z |
id |
cronfa47923 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2018-12-27T15:07:05.9437526</datestamp><bib-version>v2</bib-version><id>47923</id><entry>2018-12-10</entry><title>Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness</title><swanseaauthors><author><sid>fdab5e9e2fe06c93d3ffa19c816bdcf6</sid><firstname>John</firstname><surname>Wagstaff</surname><name>John Wagstaff</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-12-10</date><deptcode>SGMED</deptcode><abstract/><type>Journal Article</type><journal>European Urology Oncology</journal><volume>1</volume><journalNumber>6</journalNumber><paginationStart>449</paginationStart><paginationEnd>458</paginationEnd><publisher/><issnPrint>25889311</issnPrint><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-12-31</publishedDate><doi>10.1016/j.euo.2018.06.004</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School - School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>SGMED</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2018-12-27T15:07:05.9437526</lastEdited><Created>2018-12-10T13:49:04.7720932</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Beth S.</firstname><surname>Woods</surname><order>1</order></author><author><firstname>Eleftherios</firstname><surname>Sideris</surname><order>2</order></author><author><firstname>Matthew R.</firstname><surname>Sydes</surname><order>3</order></author><author><firstname>Melissa R.</firstname><surname>Gannon</surname><order>4</order></author><author><firstname>Mahesh K.B.</firstname><surname>Parmar</surname><order>5</order></author><author><firstname>Mymoona</firstname><surname>Alzouebi</surname><order>6</order></author><author><firstname>Gerhardt</firstname><surname>Attard</surname><order>7</order></author><author><firstname>Alison J.</firstname><surname>Birtle</surname><order>8</order></author><author><firstname>Susannah</firstname><surname>Brock</surname><order>9</order></author><author><firstname>Richard</firstname><surname>Cathomas</surname><order>10</order></author><author><firstname>Prabir R.</firstname><surname>Chakraborti</surname><order>11</order></author><author><firstname>Audrey</firstname><surname>Cook</surname><order>12</order></author><author><firstname>William R.</firstname><surname>Cross</surname><order>13</order></author><author><firstname>David P.</firstname><surname>Dearnaley</surname><order>14</order></author><author><firstname>Joanna</firstname><surname>Gale</surname><order>15</order></author><author><firstname>Stephanie</firstname><surname>Gibbs</surname><order>16</order></author><author><firstname>John D.</firstname><surname>Graham</surname><order>17</order></author><author><firstname>Robert</firstname><surname>Hughes</surname><order>18</order></author><author><firstname>Rob J.</firstname><surname>Jones</surname><order>19</order></author><author><firstname>Robert</firstname><surname>Laing</surname><order>20</order></author><author><firstname>Malcolm D.</firstname><surname>Mason</surname><order>21</order></author><author><firstname>David</firstname><surname>Matheson</surname><order>22</order></author><author><firstname>Duncan B.</firstname><surname>McLaren</surname><order>23</order></author><author><firstname>Robin</firstname><surname>Millman</surname><order>24</order></author><author><firstname>Joe M.</firstname><surname>O'Sullivan</surname><order>25</order></author><author><firstname>Omi</firstname><surname>Parikh</surname><order>26</order></author><author><firstname>Christopher C.</firstname><surname>Parker</surname><order>27</order></author><author><firstname>Clive</firstname><surname>Peedell</surname><order>28</order></author><author><firstname>Andrew</firstname><surname>Protheroe</surname><order>29</order></author><author><firstname>Alastair W.S.</firstname><surname>Ritchie</surname><order>30</order></author><author><firstname>Angus</firstname><surname>Robinson</surname><order>31</order></author><author><firstname>J. Martin</firstname><surname>Russell</surname><order>32</order></author><author><firstname>Matthew S.</firstname><surname>Simms</surname><order>33</order></author><author><firstname>Narayanan N.</firstname><surname>Srihari</surname><order>34</order></author><author><firstname>Rajaguru</firstname><surname>Srinivasan</surname><order>35</order></author><author><firstname>John N.</firstname><surname>Staffurth</surname><order>36</order></author><author><firstname>Santhanam</firstname><surname>Sundar</surname><order>37</order></author><author><firstname>George N.</firstname><surname>Thalmann</surname><order>38</order></author><author><firstname>Shaun</firstname><surname>Tolan</surname><order>39</order></author><author><firstname>Anna T.H.</firstname><surname>Tran</surname><order>40</order></author><author><firstname>David</firstname><surname>Tsang</surname><order>41</order></author><author><firstname>John</firstname><surname>Wagstaff</surname><order>42</order></author><author><firstname>Nicholas D.</firstname><surname>James</surname><order>43</order></author><author><firstname>Mark J.</firstname><surname>Sculpher</surname><order>44</order></author></authors><documents/><OutputDurs/></rfc1807> |
spelling |
2018-12-27T15:07:05.9437526 v2 47923 2018-12-10 Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness fdab5e9e2fe06c93d3ffa19c816bdcf6 John Wagstaff John Wagstaff true false 2018-12-10 SGMED Journal Article European Urology Oncology 1 6 449 458 25889311 31 12 2018 2018-12-31 10.1016/j.euo.2018.06.004 COLLEGE NANME Medical School - School COLLEGE CODE SGMED Swansea University 2018-12-27T15:07:05.9437526 2018-12-10T13:49:04.7720932 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Beth S. Woods 1 Eleftherios Sideris 2 Matthew R. Sydes 3 Melissa R. Gannon 4 Mahesh K.B. Parmar 5 Mymoona Alzouebi 6 Gerhardt Attard 7 Alison J. Birtle 8 Susannah Brock 9 Richard Cathomas 10 Prabir R. Chakraborti 11 Audrey Cook 12 William R. Cross 13 David P. Dearnaley 14 Joanna Gale 15 Stephanie Gibbs 16 John D. Graham 17 Robert Hughes 18 Rob J. Jones 19 Robert Laing 20 Malcolm D. Mason 21 David Matheson 22 Duncan B. McLaren 23 Robin Millman 24 Joe M. O'Sullivan 25 Omi Parikh 26 Christopher C. Parker 27 Clive Peedell 28 Andrew Protheroe 29 Alastair W.S. Ritchie 30 Angus Robinson 31 J. Martin Russell 32 Matthew S. Simms 33 Narayanan N. Srihari 34 Rajaguru Srinivasan 35 John N. Staffurth 36 Santhanam Sundar 37 George N. Thalmann 38 Shaun Tolan 39 Anna T.H. Tran 40 David Tsang 41 John Wagstaff 42 Nicholas D. James 43 Mark J. Sculpher 44 |
title |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness |
spellingShingle |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness John Wagstaff |
title_short |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness |
title_full |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness |
title_fullStr |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness |
title_full_unstemmed |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness |
title_sort |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness |
author_id_str_mv |
fdab5e9e2fe06c93d3ffa19c816bdcf6 |
author_id_fullname_str_mv |
fdab5e9e2fe06c93d3ffa19c816bdcf6_***_John Wagstaff |
author |
John Wagstaff |
author2 |
Beth S. Woods Eleftherios Sideris Matthew R. Sydes Melissa R. Gannon Mahesh K.B. Parmar Mymoona Alzouebi Gerhardt Attard Alison J. Birtle Susannah Brock Richard Cathomas Prabir R. Chakraborti Audrey Cook William R. Cross David P. Dearnaley Joanna Gale Stephanie Gibbs John D. Graham Robert Hughes Rob J. Jones Robert Laing Malcolm D. Mason David Matheson Duncan B. McLaren Robin Millman Joe M. O'Sullivan Omi Parikh Christopher C. Parker Clive Peedell Andrew Protheroe Alastair W.S. Ritchie Angus Robinson J. Martin Russell Matthew S. Simms Narayanan N. Srihari Rajaguru Srinivasan John N. Staffurth Santhanam Sundar George N. Thalmann Shaun Tolan Anna T.H. Tran David Tsang John Wagstaff Nicholas D. James Mark J. Sculpher |
format |
Journal article |
container_title |
European Urology Oncology |
container_volume |
1 |
container_issue |
6 |
container_start_page |
449 |
publishDate |
2018 |
institution |
Swansea University |
issn |
25889311 |
doi_str_mv |
10.1016/j.euo.2018.06.004 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
0 |
active_str |
0 |
published_date |
2018-12-31T03:58:09Z |
_version_ |
1763752950206824448 |
score |
11.02167 |